Skip to main content
Settings
Search
Appearance
Theme Mode
About
Jekyll v3.10.0
Environment Production
Last Build
2026-06-19 10:04 UTC
Current Environment Production
Build Time Jun 19, 10:04
Jekyll v3.10.0
Build env (JEKYLL_ENV) production
Quick Links
Page Location
Source Code

Set repository: USER/REPO in your _config.yml to enable source-code shortcuts.

Page Info
Layout default
Collection none
Path science-technology/h1n1-swine-flu-pandemic.md
URL /science-technology/h1n1-swine-flu-pandemic/
Date 2009-04-01
Theme Skin
SVG Backgrounds
Layer Opacity
0.6
0.04
0.08

Table of Contents

2009 H1N1 Swine Flu Pandemic

Category: Science & Technology Key figures: Margaret Chan (WHO Director-General), Thomas Frieden (CDC Director from June 2009), Anne Schuchat (CDC)

Summary

In April 2009, a novel influenza A (H1N1) virus of swine origin emerged simultaneously in Mexico and the United States, triggering the first influenza pandemic of the 21st century. An outbreak of influenza-like illness began in Veracruz, Mexico, around April 4, 2009, with severe cases reported in Mexico City by April 15. The World Health Organization issued its first Disease Outbreak Notice on April 24, and by April 25 community-level outbreaks had been confirmed in Mexico. The virus spread rapidly across borders due to international air travel; within weeks it had been reported in dozens of countries. On June 11, 2009, WHO Director-General Margaret Chan raised the pandemic alert to Phase 6 — the highest level, indicating a global pandemic — making it the first influenza pandemic declared since 1968. At the time of declaration, more than 70 countries had reported confirmed cases.

The virus was genetically distinct from previous H1N1 strains, carrying gene segments from North American swine, Eurasian swine, human, and avian influenza viruses. Unlike seasonal influenza, which disproportionately kills the elderly, approximately 80 percent of H1N1-related deaths occurred in people under age 65. Governments worldwide mobilized to develop and distribute a vaccine: seed viruses were isolated and sequenced by May 2009, NIH-sponsored clinical trials began in August, and the US Food and Drug Administration approved four monovalent H1N1 vaccines in September 2009. Mass vaccination campaigns followed in the autumn of 2009. WHO declared the pandemic over on August 10, 2010.

Initial WHO laboratory-confirmed death counts stood at approximately 18,449, but subsequent analyses by CDC-led research teams estimated the true global toll at between 151,700 and 575,400 deaths during the first year, with a central estimate of approximately 284,000 — roughly fifteen times the confirmed count — because most deaths in lower-income countries were never laboratory-tested. When respiratory and cardiovascular deaths attributable to H1N1 are combined, some analyses place the total as high as 400,000.

Significance

The 2009 H1N1 pandemic was the first pandemic influenza event since 1968 and the first pandemic of any kind declared under the 2005 International Health Regulations framework. It tested global public health infrastructure at every level: surveillance networks, international data-sharing, vaccine manufacturing capacity, and risk communication. The unprecedented speed of vaccine development — from sequence to licensed product in approximately five months — demonstrated what was then possible and set a benchmark that informed the even faster COVID-19 vaccine development a decade later. Epidemiological and virological data gathered during the pandemic contributed directly to improved pandemic preparedness protocols and revisions to WHO pandemic phase definitions adopted in 2013. The wide discrepancy between confirmed and estimated death tolls also drove major investments in mortality surveillance in low- and middle-income countries.

Sources